Orinda Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Orinda Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,000	Closed	-$339K	–	181
2014 Q4	$339K	Buy	+20,000	New	+$281K	0.38%	44

Orinda Asset Management's AVNR Position: Q1 2015 in Review

Orinda Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 20,000 shares — an estimated $339K sold.

Orinda Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $339K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Orinda Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Orinda Asset Management sold 20,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $339K.
Orinda Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Orinda Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $339K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Orinda Asset Management's 13F filing for Q1 2015, filed 12 May 2015.